Grants and Contributions:
Title:
Innovation Assistance Program – Round 2.5
Agreement Number:
967036
Agreement Value:
$5,419.00
Agreement Date:
Dec 20, 2020 - Mar 13, 2021
Description:
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
Organization:
National Research Council Canada
Expected Results:
The purpose of IAP is to provide support to assist innovative, early-stage companies that are unable to access other COVID-19 business supports.
Location:
Toronto, Ontario, CA M5G 1M1
Reference Number:
172-2020-2021-Q4-967036
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
736405325
Recipient Type:
For-profit organization
Recipient's Legal Name:
Bright Angel Therapeutics Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Innovation Assistance Program
Program Purpose:
The purpose of IAP is to provide support to assist innovative, early-stage companies that are unable to access other COVID-19 business supports.
Coverage:
IRAP IAP Contributions provide wage support to early-stage, innovative firms and help position them for future growth and wealth creation for Canada through technological innovation.